As of 2025-10-16, the EV/EBITDA ratio of Precision BioSciences Inc (DTIL) is -0.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DTIL's latest enterprise value is 36.75 mil USD. DTIL's TTM EBITDA according to its financial statements is -76.98 mil USD. Dividing these 2 quantities gives us the above DTIL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 13.4x | 11.0x |
| Forward P/E multiples | 15.7x - 20.4x | 18.0x |
| Fair Price | (53.42) - 7.43 | (30.90) |
| Upside | -921.8% - 14.3% | -575.4% |
| Date | EV/EBITDA |
| 2025-10-14 | -0.38 |
| 2025-10-13 | -0.33 |
| 2025-10-10 | -0.34 |
| 2025-10-09 | -0.38 |
| 2025-10-08 | -0.35 |
| 2025-10-07 | -0.35 |
| 2025-10-06 | -0.35 |
| 2025-10-03 | -0.32 |
| 2025-10-02 | -0.31 |
| 2025-10-01 | -0.32 |
| 2025-09-30 | -0.33 |
| 2025-09-29 | -0.26 |
| 2025-09-26 | -0.26 |
| 2025-09-25 | -0.24 |
| 2025-09-24 | -0.27 |
| 2025-09-23 | -0.23 |
| 2025-09-22 | -0.23 |
| 2025-09-19 | -0.21 |
| 2025-09-18 | -0.23 |
| 2025-09-17 | -0.18 |
| 2025-09-16 | -0.20 |
| 2025-09-15 | -0.17 |
| 2025-09-12 | -0.19 |
| 2025-09-11 | -0.25 |
| 2025-09-10 | -0.25 |
| 2025-09-09 | -0.26 |
| 2025-09-08 | -0.24 |
| 2025-09-05 | -0.26 |
| 2025-09-04 | -0.25 |
| 2025-09-03 | -0.26 |
| 2025-09-02 | -0.25 |
| 2025-08-29 | -0.23 |
| 2025-08-28 | -0.25 |
| 2025-08-27 | -0.25 |
| 2025-08-26 | -0.25 |
| 2025-08-25 | -0.27 |
| 2025-08-22 | -0.24 |
| 2025-08-21 | -0.21 |
| 2025-08-20 | -0.20 |
| 2025-08-19 | -0.22 |
| 2025-08-18 | -0.24 |
| 2025-08-15 | -0.20 |
| 2025-08-14 | -0.21 |
| 2025-08-13 | -0.20 |
| 2025-08-12 | -0.15 |
| 2025-08-11 | -0.15 |
| 2025-08-08 | -0.15 |
| 2025-08-07 | -0.18 |
| 2025-08-06 | -0.22 |
| 2025-08-05 | -0.23 |